Effectiveness and compliance of long lasting insecticide – treated nets (LLINs) on malaria parasitemia in some pregnant women attending antenatal clinic in Rivers State Nigeria.  by Nduka, F. & Wogu, M.
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Results of the present study provides evidence that any case of
ever is malaria until proven otherwise still holds true for tropical
ountries like India.
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ffectiveness and compliance of long lasting insecticide –
reated nets (LLINs) on malaria parasitemia in some pregnant
omen attending antenatal clinic in Rivers State Nigeria.
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Background: A study to evaluate the effectiveness and compli-
nce of long lasting insecticide – treated nets (LLINs) on malaria
arasitemia in some pregnant women attending antenatal clinic
n ﬁve healthcare centres in Rivers State was carried out to offer
nsight into Government efforts at Bednet distribution.
Methods:A total of 400 pregnantwomen in different trimesters
ere examined for malaria parasites. Blood samples were col-
ected by vein puncture and the presence of malaria parasites was
bserved microscopically on thick and thin blood smears prepared
rom each sample. Personal data were also collected through ques-
ionnaires. The results gotten were analyzed statistically using the
hi – square test of signiﬁcance.
Results: A total of 104 (26%) pregnant women out of the 400
xamined were infected. Out of the 400 pregnant women exam-
ned, 317 (79%) used LLINs while 83 (21%) did not. Of the 317
hat used insecticide – treated bednets, 29 (9%) were positive for
alaria parasite while 75(90.4%)of the 83 that did not use insec-
icide bednets were positive for malaria parasite (P <0.05). Ebony
ospital had the highest compliance rate in the usage of LLINs at
6%while Aluuhealthcare centre had the lowest compliance rate at
2% (P <0.05). Those attending ANC in Private Health facilities had
0% compliancewhile 72.8% of those attending ANC in government
ealthcare centres used LLINs (P <0.05). Pregnant women in their
rst, second and third trimesters that used LLINs had prevalence
ates of 5.3%, 12.2%and11.5% respectivelywhile those in equivalent
rimesters that didnot use LLINshad83.6%, 94.1% and90.9% respec-
ively. Primigraviidae, secundigraviidae and multiparous women
hat used LLINs had prevalence rates of 10.3%, 8.7% and 5.9% respec-
ively while their counterparts who did not use LLINs had 95.8%,
9.5% and 75% respectively, (P <0.05). Increased levels of formal
ducation enhanced the compliance and usage of LLINs.
Conclusion: LLINSwas effective in the control of malaria and
fforts should be made to ensure high compliance rates as shown
n the study.
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Clinical investigation of in-vivo susceptibility ofP. falciparum to
artesunate in Binh Phuoc Province, Vietnam
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Background: Since 2005 the ﬁrst-choice treatment for uncom-
plicated falciparum malaria recommended in Vietnam has been
the combinationof dihydroartemisinin (ametabolite of artesunate)
andpiperaquine. There areworrying signs of artemisinin resistance
inWesternCambodia. Vietnamshares a long landborderwithCam-
bodia and a large number of people cross that border on a regular
basis. In this context there is an urgent need to investigate whether
there is any evidence of resistance to artemisinin derivatives in
Vietnam.
Methods: This is a randomized clinical descriptive study in
uncomplicated falciparum malaria, comparing two different arms
of artesunate therapy (2 or 4mg/kg/day for 3 days) and an arm
of dihydroartemisinin-piperaquine for 3 days. Clinical and para-
sitological parameters were monitored over a 42-day follow-up
period.
Results: From August 2010 to May 2011, we recruited 166
patients into the study at the time of completion. Admission clin-
ical parameters and laboratory investigations were similar in 3
randomised groups. Fever clearance times did not differ signiﬁ-
cantly between the three study arms (artesunate 2mg/kg, 4mg/kg
and dihydroartemisinin-piperaquine) (30,24 and 24hrs; p =0.86).
Early treatment failure occurred in 3 (5%) and late clinical failure
occurred in 1 (2%) of the 55 patients in artesunate 2mg/kg arm,
as compared with none in other 2 study arms. Late parasitological
failure occurred in 1 (2%) of the 55 patients in dihydroartemisinin-
piperaquine arm. The rate of adequate clinical and parasitological
responses in 3 groups were 84%, 82% and 93%. Parasite clearance
time was not signiﬁcantly different between 3 regimens (p= 0.49).
The proportions of patients had parasitemia at 72hours were 27%,
27% and 22% after starting the treatment. The median parasite-
reduction ratios at 24hourswere 2.07% (interquartile range, 0.36 to
20.11), 0.49% (IR, 0.03 to 8.88) and 0.88% (IR, 0.18 to 8.49) (p =0.02).
Conclusion: This study indicates there is a suspected resistance
to artemisinin derivatives in the study site. The parasite-reduction
ratio at 24hours was signiﬁcantly slower in artesunate 2mg/kg
group. The results from the pharmacokinetic and genetic analysis
will clarify theartemisinin resistance. But, analternative antimalar-
ial regimen is not urgently needed.
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